Conditions: Autism Spectrum Disorders
Keywords: Autism Autism Spectrum Disorders irritability aberrant behavior
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 32
Healthy volunteers: no

Brief summary:
The study objective is to explore the safety and tolerability of STX209 in subjects with Autism Spectrum Disorders and to obtain preliminary data on several measures of efficacy in treating irritability. We hypothesize that STX209 will be safe and well-tolerated.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Arbaclofen
Intervention descriptions: intervention 1: variable dose from 1mg bid to 10 mg tid, oral capsule, 8 week treatment period

Protocol document: